These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 10953053

  • 1. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
    Wickenden AD, Yu W, Zou A, Jegla T, Wagoner PK.
    Mol Pharmacol; 2000 Sep; 58(3):591-600. PubMed ID: 10953053
    [Abstract] [Full Text] [Related]

  • 2. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
    Tatulian L, Delmas P, Abogadie FC, Brown DA.
    J Neurosci; 2001 Aug 01; 21(15):5535-45. PubMed ID: 11466425
    [Abstract] [Full Text] [Related]

  • 3. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
    Main MJ, Cryan JE, Dupere JR, Cox B, Clare JJ, Burbidge SA.
    Mol Pharmacol; 2000 Aug 01; 58(2):253-62. PubMed ID: 10908292
    [Abstract] [Full Text] [Related]

  • 4. Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells.
    Wickenden AD, Zou A, Wagoner PK, Jegla T.
    Br J Pharmacol; 2001 Jan 01; 132(2):381-4. PubMed ID: 11159685
    [Abstract] [Full Text] [Related]

  • 5. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
    Peretz A, Degani N, Nachman R, Uziyel Y, Gibor G, Shabat D, Attali B.
    Mol Pharmacol; 2005 Apr 01; 67(4):1053-66. PubMed ID: 15598972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retigabine stimulates human KCNQ2/Q3 channels in the presence of bupivacaine.
    Punke MA, Friederich P.
    Anesthesiology; 2004 Aug 01; 101(2):430-8. PubMed ID: 15277926
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals.
    Martire M, Castaldo P, D'Amico M, Preziosi P, Annunziato L, Taglialatela M.
    J Neurosci; 2004 Jan 21; 24(3):592-7. PubMed ID: 14736843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
    Otto JF, Yang Y, Frankel WN, Wilcox KS, White HS.
    Epilepsia; 2004 Sep 21; 45(9):1009-16. PubMed ID: 15329063
    [Abstract] [Full Text] [Related]

  • 17. PIP2 mediates functional coupling and pharmacology of neuronal KCNQ channels.
    Kim RY, Pless SA, Kurata HT.
    Proc Natl Acad Sci U S A; 2017 Nov 07; 114(45):E9702-E9711. PubMed ID: 29078287
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.